Bloomberg Law
July 21, 2021, 9:36 AM

End of Health Crisis Will Put Heaps of Covid Products in Limbo

Jeannie Baumann
Jeannie Baumann
Reporter

Covid-19 vaccines, therapies, and other related products are available in the U.S. thanks to more than 400 emergency use authorizations granted by the FDA during the pandemic.

Nearly all of those products are at risk of being taken off the market once the declaration for the public health emergency ends—unless and until they attain full approval. The Food and Drug Administration has been working on guidance for almost a year on how to transition from emergency status, but businesses need to start preparing now, attorneys say.

“The sheer volume of authorized products could be potentially very disruptive, if not transitioned ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.